Compare COGT & KVYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COGT | KVYO |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.9B |
| IPO Year | 2018 | 2023 |
| Metric | COGT | KVYO |
|---|---|---|
| Price | $26.90 | $22.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 23 |
| Target Price | ★ $55.82 | $27.17 |
| AVG Volume (30 Days) | 1.9M | ★ 4.6M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.29 |
| EPS | N/A | ★ N/A |
| Revenue | $7,871,000.00 | ★ $1,234,019,000.00 |
| Revenue This Year | N/A | $24.77 |
| Revenue Next Year | $5,819.52 | $18.88 |
| P/E Ratio | ★ N/A | $657.67 |
| Revenue Growth | N/A | ★ 31.63 |
| 52 Week Low | $26.36 | $12.53 |
| 52 Week High | $43.73 | $33.36 |
| Indicator | COGT | KVYO |
|---|---|---|
| Relative Strength Index (RSI) | 36.08 | 60.96 |
| Support Level | N/A | $15.49 |
| Resistance Level | $37.34 | $23.52 |
| Average True Range (ATR) | 1.77 | 1.24 |
| MACD | -0.36 | -0.05 |
| Stochastic Oscillator | 6.38 | 65.93 |
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.